225 related articles for article (PubMed ID: 31671453)
1. MenAfriNet: A Network Supporting Case-Based Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Africa.
Patel JC; Soeters HM; Diallo AO; Bicaba BW; Kadadé G; Dembélé AY; Acyl MA; Nikiema C; Lingani C; Hatcher C; Acosta AM; Thomas JD; Diomande F; Martin S; Clark TA; Mihigo R; Hajjeh RA; Zilber CH; Aké F; Mbaeyi SA; Wang X; Moisi JC; Ronveaux O; Mwenda JM; Novak RT;
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S148-S154. PubMed ID: 31671453
[TBL] [Abstract][Full Text] [Related]
2. Future Directions for Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Sub-Saharan Africa.
Novak RT; Ronveaux O; Bita AF; Aké HF; Lessa FC; Wang X; Bwaka AM; Fox LM
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S279-S285. PubMed ID: 31671452
[TBL] [Abstract][Full Text] [Related]
3. Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018.
Bwaka A; Bita A; Lingani C; Fernandez K; Durupt A; Mwenda JM; Mihigo R; Djingarey MH; Ronveaux O; Preziosi MP
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S140-S147. PubMed ID: 31671448
[TBL] [Abstract][Full Text] [Related]
4. Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.
Sidikou F; Zaneidou M; Alkassoum I; Schwartz S; Issaka B; Obama R; Lingani C; Tate A; Ake F; Sakande S; Ousmane S; Zanguina J; Seidou I; Nzeyimana I; Mounkoro D; Abodji O; Wang X; Taha MK; Moulia-Pelat JP; Pana A; Kadade G; Ronveaux O; Novak R; Oukem-Boyer OOM; Meyer S;
Lancet Infect Dis; 2016 Nov; 16(11):1288-1294. PubMed ID: 27567107
[TBL] [Abstract][Full Text] [Related]
5. Improving Case-Based Meningitis Surveillance in 5 Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2017.
Mbaeyi SA; Lingani C; Diallo AO; Bicaba B; Ouédraogo-Traoré R; Acyl M; Gamougame K; Coulibaly O; Coulibaly S; Zaneidou M; Sidikou F; Nikiema C; Sadji AY; Aké F; Tarbangdo F; Sakande S; Tall H; Njanpop-Lafourcade BM; Moïsi J; N'diaye A; Bwaka A; Bita A; Fernandez K; Poy A; Soeters HM; Vuong J; Novak R; Ronveaux O;
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S155-S164. PubMed ID: 31671451
[TBL] [Abstract][Full Text] [Related]
6. Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines.
Alderson MR; LaForce FM; Sobanjo-Ter Meulen A; Hwang A; Preziosi MP; Klugman KP
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S274-S278. PubMed ID: 31671447
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of meningitis surveillance before introduction of serogroup a meningococcal conjugate vaccine - Burkina Faso and Mali.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(50):1025-8. PubMed ID: 23254257
[TBL] [Abstract][Full Text] [Related]
8. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
Xie O; Pollard AJ; Mueller JE; Norheim G
Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
[TBL] [Abstract][Full Text] [Related]
9. Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.
Diallo AO; Soeters HM; Yameogo I; Sawadogo G; Aké F; Lingani C; Wang X; Bita A; Fall A; Sangaré L; Ouédraogo-Traoré R; Medah I; Bicaba B; Novak RT;
PLoS One; 2017; 12(11):e0187466. PubMed ID: 29095907
[TBL] [Abstract][Full Text] [Related]
10. The burden of meningococcal meningitis in the African Meningitis Belt, from 2009 to 2014: a trend analysis.
Jaca A; Wiyeh AB; Sambala EZ; Wiysonge CS
Pan Afr Med J; 2021; 39():57. PubMed ID: 34422180
[TBL] [Abstract][Full Text] [Related]
11. Neisseria meningitidis Serogroup W Meningitis Epidemic in Togo, 2016.
Mounkoro D; Nikiema CS; Maman I; Sakandé S; Bozio CH; Tall H; Sadji AY; Njanpop-Lafourcade BM; Sibabe A; Landoh DE; Abodji EO; Kodjo A; Tamekloe TA; Essoh TA; Maba DW; Gessner BD; Moïsi JC
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S216-S224. PubMed ID: 31671438
[TBL] [Abstract][Full Text] [Related]
12. Meningitis epidemics in Africa: a brief overview.
Teyssou R; Muros-Le Rouzic E
Vaccine; 2007 Sep; 25 Suppl 1():A3-7. PubMed ID: 17643560
[TBL] [Abstract][Full Text] [Related]
13. Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.
Novak RT; Kambou JL; Diomandé FV; Tarbangdo TF; Ouédraogo-Traoré R; Sangaré L; Lingani C; Martin SW; Hatcher C; Mayer LW; Laforce FM; Avokey F; Djingarey MH; Messonnier NE; Tiendrébéogo SR; Clark TA
Lancet Infect Dis; 2012 Oct; 12(10):757-64. PubMed ID: 22818241
[TBL] [Abstract][Full Text] [Related]
14. Bacterial Meningitis Epidemiology in Five Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2017.
Soeters HM; Diallo AO; Bicaba BW; Kadadé G; Dembélé AY; Acyl MA; Nikiema C; Sadji AY; Poy AN; Lingani C; Tall H; Sakandé S; Tarbangdo F; Aké F; Mbaeyi SA; Moïsi J; Paye MF; Sanogo YO; Vuong JT; Wang X; Ronveaux O; Novak RT;
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S165-S174. PubMed ID: 31671441
[TBL] [Abstract][Full Text] [Related]
15. Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.
Mohammed I; Iliyasu G; Habib AG
Pathog Glob Health; 2017 Feb; 111(1):1-6. PubMed ID: 28081671
[TBL] [Abstract][Full Text] [Related]
16. Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.
; Altmann D; Aseffa A; Bash M; Basta N; Borrow R; Broome C; Caugant D; Clark T; Collard JM; Djingarey M; Goldblatt D; Greenwood B; Griffiths U; Hajjeh R; Hassan-King M; Hugonnet S; Kimball AM; LaForce M; MacLennan C; Maiden MC; Manigart O; Mayer L; Messonnier N; Moisi J; Moore K; Moto DD; Mueller J; Nascimento M; Obaro S; Ouedraogo R; Page AL; Perea W; Pluschke G; Preziosi MP; Sow S; Stephens D; Stuart J; Thomson M; Tiendrebeogo S; Trape JF; Vernet G
Vaccine; 2013 Mar; 31(11):1453-7. PubMed ID: 23273967
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of Bacterial Meningitis in the Nine Years Since Meningococcal Serogroup A Conjugate Vaccine Introduction, Niger, 2010-2018.
Sidikou F; Potts CC; Zaneidou M; Mbaeyi S; Kadadé G; Paye MF; Ousmane S; Issaka B; Chen A; Chang HY; Issifou D; Lingani C; Sakande S; Bienvenu B; Mahamane AE; Diallo AO; Moussa A; Seidou I; Abdou M; Sidiki A; Garba O; Haladou S; Testa J; Obama Nse R; Mainassara HB; Wang X
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S206-S215. PubMed ID: 31671439
[TBL] [Abstract][Full Text] [Related]
18. Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010-2014.
Djingarey MH; Diomandé FV; Barry R; Kandolo D; Shirehwa F; Lingani C; Novak RT; Tevi-Benissan C; Perea W; Preziosi MP; LaForce FM
Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S434-41. PubMed ID: 26553672
[TBL] [Abstract][Full Text] [Related]
19. Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.
Mustapha MM; Harrison LH
Hum Vaccin Immunother; 2018 May; 14(5):1107-1115. PubMed ID: 29211624
[TBL] [Abstract][Full Text] [Related]
20. Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012.
Cibrelus L; Medah I; Koussoubé D; Yélbeogo D; Fernandez K; Lingani C; Djingarey M; Hugonnet S
Emerg Infect Dis; 2015 Nov; 21(11):2063-6. PubMed ID: 26488128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
